ARTICLE | Clinical News
MLB reports Phase II Devacade data
August 20, 2001 7:00 AM UTC
ML Laboratories (LSE:MLB) said that its Devacade opiate in combination with standard therapy gave significantly improved pain relief compared to standard therapy alone in half the patients receiving t...